学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

安藤美樹（アンドウミキ）

研究テーマ	iPS細胞を用いる若返りT細胞療法
研究業績（論文）	1. Tamayose K, Sugimoto K, Ando M, Oshimi K. Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts. Blood 97: 2524, 2001 2. Ando M, Tamayose K, Sugimoto K, Oshimi K. Secondary myelodysplasticsyndrome after treatment of prostate cancer with oral estramustine. American Journal of Hematology 67: 274-275, 2001 3. Tamayose K, Sugimoto K, Ando M, Oshimi K. Mononucleosis syndrome and acute monocytic leukemia. European Journal of Haematology 68: 236-238, 2002 4. Ando M, Isobe Y, Sasaki M, Sugimoto K, Ando J, Oshimi K. Diffuse large B-cell lymphoma expressing surface immunoglobulin heavy chain (Ig alpha) and lacking light chains. Rinsho Ketsueki 46: 492-495, 2005 5. Ando M, Sugimoto K, Kitoh T, Sasaki M, Mukai K, Ando J, Egasira M, Schuster SM, Oshimi K. Selective apoptosis of natural killer-cell tumours by l-asparaginase. British Journal of Haematology 130: 860-868, 2005 6. Sasaki M, Sugimoto K, Tamayose K, Ando M, Tanaka Y, Oshimi K. Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax. Oncogene 25(26):3621-7, 2006 7. Ando J, Sugimoto K, Tamayose K, Ando M, Kojima Y, Oshimi K. Cytokine-producing sarcoma mimics eosinophilic leukaemia. European Journal of Haematology 78: 169-170, 2007 8. Ando J, Sugimoto K, Tamayose K, Sasaki M, Ando M, Oshimi K. Changes in cell morphology and cytoskeletal organization are induced by human mitotic checkpoint gene, Bub1. Biochemical Biophysical Research Communication 365: 691-697, 2008 9. Sugimoto K, Sasaki M, Isobe Y, Tsutsui M, Suto H, Ando J, Tamayose K, Ando M, Oshimi K. Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1. Oncogene 27(22):3091-101, 2008 10. Ando J, Sugimoto K, Ando M, Sasaki M, Oshimi K. CD20-positive extranodal NK-cell lymphoma, nasal-type. European Journal of Haematology 80: 549-550, 2008 11. Miki Ando, Valentina Hoyos, Shigeki Yagyu, Wade Tao, Carlos A. Ramos, Gianpietro Dotti, Malcolm K. Brenner and Lisa Bouchier-Hayes Bortezomib sensitizes non small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity Cancer Gene Therapy 21(11):472-82, 2014 12. Hoyos V, Del Bufalo F, Yagyu S, Ando M, Dotti G, Suzuki M, Bouchier-Hayes L, Alemany R, Brenner MK. Mesenchymal stromal cells for linked delivery of oncolytic and apoptotic adenoviruses to non-small cell lung cancers Molecular Therapy 23(9):1497-506, 2015 13. Miki Ando, Toshinobu Nishimura, Satoshi Yamazaki, Tomoyuki Yamaguchi, Ai Kawana-Tachikawa, Tomonari Hayama, Yusuke Nakauchi, Jun Ando, Yasunori Ota, Satoshi Takahashi, Ken Nishimura, Manami Ohtaka, Mahito Nakanishi, John J Miles, Scott R Burrows, Malcolm K Brenner, and Hiromitsu Nakauchi A Safeguard System for Induced Pluripotent Stem-Cell Derived Rejuvenated T-cell Therapy Stem Cell Reports 5(4):597-608, 2015 14. Miki Ando and Hiromitsu Nakauchi “Off-the-shelf” Immunotherapy with iPSC-Derived Rejuvenated Cytotoxic T Lymphocytes Experimental Hematology 47:2-12, 2017 15. Go Itakura, Soya Kawabata, Miki Ando, Yuichiro Nishiyama, Keiko Sugai, Masahiro Ozaki, Tsuyoshi Iida, Toshiki Ookubo, Kota Kojima, Rei Kashiwagi, Kaori Yasutake, Hiromitsu Nakauchi, Hiroyuki Miyoshi, Narihito Nagoshi, Jun Kohyama, Akio Iwanami, Morio Matsumoto, Masaya Nakamura, and Hideyuki Okano. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives Stem Cell Reports 8(3):673-684, 2017 16. Mana Iizuka-Koga, Hiromitsu Asashima, Miki Ando, Chen-Yi Lai, Shinji Mochizuki, Mahito Nakanishi, Toshinobu Nishimura, Hiroto Tsuboi, Tomoya Hirota, Hiroyuki Takahashi, Isao Matsumoto, Makoto Otsu, Takayuki Sumida Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome Stem Cell Reports 8(5):1155-1163, 2017 17. Ando M, Nakauchi H, Komatsu N. iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas. Rinsho Ketsueki 59(7): 932-938, 2018 18. Miki Ando, Jun Ando, Satoshi Yamazaki, Midori Ishii, Yumi Sakiyama, Sakiko Harada, Tadahiro Honda, Tomoyuki Yamaguchi, Masanori Nojima, Koichi Ohshima, Hiromitsu Nakauchi and Norio Komatsu：Long-term eradication of extranodal NK/T cell lymphoma, nasal type, by iPSC-derived Epstein-Barr virus - specific rejuvenated T cells in vivo. Haematologica 105(3): 796-807, 2020 19. Jun Ando, Minhtran C. Ngo, Miki Ando, Ann Leen and Cliona M. Rooney: Identification of protective T-cell antigens for smallpox vaccines. Cytotherapy 22(11): 642-652, 2020 20. Miki Ando, Jun Ando, Tadahiro Honda, Midori Ishii, Hiromitsu Nakauchi, and Norio Komatsu：iPSC-derived rejuvenated T cell therapy for Extranodal NK/T-cell lymphoma, nasal type. Juntendo Medical Journal 66(3): 200-205, 2020 21. Tadahiro Honda, Miki Ando, Jun Ando, Midori Ishii, Yumi Sakiyama, Kazuo Ohara, Tokuko Toyota, Manami Ohtaka, Ayako Masuda, Yasuhisa Terao, Mahito Nakanishi, Hiromitsu Nakauchi, and Norio Komatsu: Sustainable tumor suppressive effect of iPSC-derived rejuvenated T cells targeting cervical cancers. Molecular Therapy 28(11): 2394-2405, 2020 22. Jun Ando, Yuji Ueno, Hajime Yasuda, Miki Ando, Yoko Edahiro, Tadahiro Honda, Masashi Takanashi, Daisuke Taniguchi, Nobutaka Hattori, Norio Komatsu: Radiation induced myopathy developing in a Hodgkin lymphoma patient: an autopsy case with systemic muscle sampling. Case Reports in Oncology 14: 338-342, 2021 23. Tomonori Ochiai, Jun Ando, Sakiko Harada, Makoto Hiki, Miki Ando, Norio Komatsu: Immune thrombocytopenia associated with asymptomatic COVID-19 infection. Rinsho Ketsueki 62(1): 58-60, 2021 24. Yoshiki Furukawa, Jun Ando, Miki Ando, Shintaro Kinoshita, Yoko Edahiro, Takuya Furuta, Koichi Ohshima, Norio Komatsu: Long-term spontaneous regression of Stage IV diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology 61(3): 168-172, 2021 25. Yoshiki Furukawa, Miki Ando, Yoko Azusawa, Shintaro Kinoshita, Sakiko Harada, Tomonori Ochiai, Tadahiro Honda, Kazuya Sugimoto, Yoko Tabe, Norio Komatsu, Jun Ando: Persistent immune thrombocytopaenic purpura associated with SARS-Cov-2 infection. eJHaem 2(3): 530-533, 2021 26. Sakiko Harada, Jun Ando, Miki Ando, Hideaki Nitta, Tadaaki Inano, Yusuke Hirasawa, Yoshiki Furukawa, Shintaro Kinoshita, Koichi Ohshima, Norio Komatsu: High-grade primary central nervous system lymphomatoid granulomatosis: Successfully rituximab monotherapy Internal Medicine 60(23): 3795-3799, 2021 27. Takeshi Mori, Hiroshi Abe, Mitutaka Yoshida, Yutaka Tsukune, Yuriko Yahata, Tomoiku Takaku, Jun Ando, Miki Ando, Shinichi Torii, and Makoto Sasaki: Immunohistochemical detection of aflatoxin in lesions of aflatoxin-producing Aspergillus flavus infection. Medical Mycology Journal 62(3): 47-52, 2021 28. Shintaro Kinoshita, Jun Ando, Miki Ando, Norio Komatsu: Primary lymphoma of the pericardium. Internal Medicine 60(24): 4005-4006, 2021 29. Sakiko Harada, Jun Ando, Miki Ando, Yoko Azusawa, Tomonori Ochiai, Yoshinori Hashimoto, Yusuke Hirasawa, Norio Komatsu: Sarcoma-like appearance but pathologic Hodgkin lymphoma. International Journal of Hematology 114:1-2, 2021 30. Kazuo Ohara, Shintaro Kinoshita, Jun Ando, Yoko Azusawa, Midori Ishii, Sakiko Harada, Yoichiro Mitsuishi, Tetsuhiko Asao, Ken Tajima, Taketsugu Yamamoto, Fumiyuki Takahashi, Norio Komatsu, Kazuhisa Takahashi, Miki Ando: SCLC-J1, a novel small cell lung cancer cell line. Biochemistry and Biophysics Reports 27: 101089, 2021 31. Midori Ishii, Jun Ando, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Yoshiki Furukawa, Yoshiyuki Suehara, Mahito Nakanishi, Kazutaka Nakashima, Koichi Ohshima, Hiromitsu Nakauchi, Miki Ando: iPSC-derived neoantigen-specific cytotoxic T lymphocyte therapy for Ewing sarcoma Cancer Immunology Research 9(10): 1175-1186, 2021 32. Shintaro Kinoshita, Miki Ando, Jun Ando, Midori Ishii, Yoshiki Furukawa, Osamu Tomita, Shuichi Shirane, Yoshihito Kishita, Yukiko Yatsuka, Hidetaka Eguchi, Yasushi Okazaki, and Norio Komatsu: Trigenic ADH5 / ALDH2 / ADGRV1 mutations in myelodysplasia with Usher syndrome. Heliyon, 7(8), e07804, 2021 33. Sakiko Harada, Miki Ando, Jun Ando, Midori Ishii, Tomoyuki Yamaguchi, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Yozo Nakazawa, Hiromitsu Nakauchi, and Norio Komatsu: Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomas. Molecular Therapy 30 (2): 534-549, 2022 34. Yoshiki Furukawa, Yasuharu Hamano, Shuichi Shirane, Shintaro Kinoshita, Yoko Azusawa, Jun Ando, Hiromitsu Nakauchi and Miki Ando: Advances in allogeneic cancer cell therapy and future perspectives on “off-the-shelf” T cell therapy using iPSC technology and gene editing. Cells 11: 269, 2022 35. Naoki Watanabe, Tomoiku Takaku, Yutaka Tsukune, Hajime Yasuda, Tomonori Ochiai, Kohei Yamada, Hiroki Nakazawa, Saori Hotta, Takayasu Nishimaki, Haruhi Takagi, Kazuhisa Takahashi, Norio Komatsu, Miki Ando: Bosutinib-induced lung injury: A report of two cases and literature review. International Journal of Hematology 115(6): 902-905, 2022. 36. Ayana Uchimura, Hajime Yasuda, Jun Ando, Yasunori Ota, Makoto Sasaki, Tomoiku Takaku, Yutaka Tsukune, Miyuki Tsutsui, Yoko Edahiro, Naoki Watanabe, Tomonori Ochiai, Norio Komatsu, Miki Ando: Hodgkin lymphoma on hemodialysis successfully treated with extended courses of brentuximab vedotin. Case Reports in Oncology 15(1): 263-266, 2022 37. Hajime Yasuda, Taku Hatano, Tadahiro Honda, Miyuki Tsutsui, Nobutaka Hattori, Miki Ando, Norio Komatsu: Vitamin B6 deficiency anemia attributed to levodopa/carbidopa intestinal gel therapy for Parkinson’s disease: a diagnostic pitfall for myelodysplastic syndrome with ring sideroblasts. Internal Medicine, March 2022 38. Hajime Yasuda, Yoshiki Furukawa, Kenya Nishioka, Makoto Sasaki, Yutaka Tsukune, Shuichi Shirane, Nobutaka Hattori, Miki Ando, Norio Komatsu: Vitamin B6 deficiency as a cause of polyneuropathy in POEMS syndrome: rapid recovery with supplementation in two cases. Hematology (Taylor & Francis), March 2022 39. Hajime Yasuda, Jun Ando, Sayako Yoshida, Yasunori Ota, Norio Komatsu, Miki Ando: Diffuse large B-cell lymphoma with adrenal involvement presenting as other iatrogenic immunodeficiency-associated lymphoproliferative disorders: sustained remission with methotrexate termination alone in two cases. Internal Medicine, May 2022 40. Federico De Marchi, Maho Okuda, Soji Morishita, Misa Imai, Terumi Baba, Mei Horino, Yosuke Mori, Chiho Furuya, Satoko Ogata, Yinjie Yang, Jun Ando, Miki Ando, Marito Araki, Norio Komatsu: Clinical and biological relevance of CREB3L1 in Philadelphia 1 chromosome-negative myeloproliferative neoplasms. Leukemia Research, May 2022 41. Yosuke Mori, Marito Araki, Soji Morishita, Misa Imai, Yoko Edahiro, Masafumi Ito, Tomonori Ochiai, Shuichi Shirane, Yoshinori Hashimoto, Hajime Yasuda, Jun Ando, Miki Ando, Norio Komatsu: Clinical features of acquired erythrocytosis: low level of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients. Cancer Medicine, June 2022 42. Hajime Yasuda, Norio Komatsu, Jun Ando, Miki Ando: Hodgkin lymphoma on hemodialysis: a review of treatment and recommendations. Clinical Lymphoma, Myeloma and Leukemia, July 2022 43. Naoki Watanabe, Tomoiku Takaku, Isao Fujioka, Shun Tsuchiya, Miki Ando: Bosutinib-induced late-onset severe liver injury preceded by eosinophilia. Annals of Hematology, Aug 2022 44. Hajime Yasuda, Yasunobu Hoshino, Jun Ando, Mayu Miyachi, Monami Osawa, Nobutaka Hattori, Miki Ando: Vitamin B6 deficiency polyneuropathy and dermatitis. The American Journal of Medicine, Sep 2022 45. Hajime Yasuda, Yuji Tomizawa, Sakiko Harada, Makoto Sasaki, Norio Komatsu, Jun Ando, Nobutaka Hattori, Miki Ando: Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib. Heliyon, Oct 2022 46. Soji Morishita, Yoshinori Hashimoto, Chiho Furuya, Yoko Edahiro, Tomonori Ochiai, Shuichi Shirane, Tadaaki Inano, Hajime Yasuda, Miki Ando, Marito Araki, Norio Komatsu: Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia. European Journal of Haematology, Oct 2022 47. Chang Liu, Misa Imai, Yoko Edahiro, Shuichi Mano, Hiraku Takei, Mai Nudejima, Akira Kurose, Soji Morishita, Miki Ando, Satoshi Tsuneda, Marito Araki, Norio Komatsu: Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms. Experimental Hematology, Nov 2022 48. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia. Journal of Thrombosis and Thrombolysis, Dec 2022 49.　Koji Tsuchiya, Yoko Edahiro, Tomoiku Takaku, Jun Ando, Miki Ando, Takashi Miida, Kinya Uchihashi, Yoko Tabe: Examinations of bone marrow aspirate using the automated hematology analyzer Sysmex XN-3000. International Journal of Laboratory Hematology, Feb 2023 50. Shun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, Miki Ando. Management and risk factors of pleural effusion in Japanese chronic myeloid leukemia patients treated with first-line dasatinib in real-world clinical practice. Internal Medicine, Feb 2023 51. Yoko Edahiro , Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, Motoaki Shiratsuchi, Kei Nakajima, Eiichi Ohtsuka, Hiroaki Tanaka, Eri Kawata, Mika Nakamae, Yasunori Ueda, Yasuo Aota, Yasumasa Sugita, Shin Ohara, Satoshi Yamasaki, Kohsuke Asagoe, Shuro Yoshida, Jun Yamanouchi, Sayaka Suzuki, Toshinori Kondo, Yuji Kanisawa, Kohtaro Toyama, Hiromi Omura, Daisuke Mizuchi, Sumio Sakamaki, Miki Ando, Norio Komatsu: Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosisk. International Journal of Hematology, Mar 2023 52. Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi and Kazuya Shimoda: Nationwide Prospective Survey of Secondary Myelofibrosis in Japan: Superiority of DIPSS-plus to MYSEC-PM as a Survival Risk Model. Blood Cancer Journal, Jun 2023；13(1): 110. doi: 10.1038/s41408-023-00869-9. 53. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano,　Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology, Jun 2023 54. Hajime Yasuda, Hikari Taka, Naoko Kaga, Tomonori Ochiai, Tomohito Yamana, Miura Yoshiki, Midori Ishii, Makoto Sasaki, Jun Ando, Miki Ando: Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma. Cancer Chemotherapy and Pharmacology, Sep 2023 55. Chiho Furuya, Soji Morishita, Yoshinori Hashimoto, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients. British Journal of Haematology, Oct 2023 56. Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi, and Kazuya Shimoda: Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Annals of Hematology, Nov 2023 57. Yoshiki Furukawa, Midori Ishii, Jun Ando, Kazuya Ikeda, Kyomi J. Igarashi, Shintaro Kinoshita, Yoko Azusawa, Tokuko Toyota, Tadahiro Honda, Mahito Nakanishi, Koichi Ohshima, Ayako Masuda, Emiko Yoshida, Mari Kitade, Matthew Porteus, Yasuhisa Terao, Hiromitsu Nakauchi, and Miki Ando: iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer. Cell Reports Medicine, Nov 2023; 4(12): 101327. doi: 10.1016. co-first author 58. Shoko Sato, Midori Ishii, Kota Tachibana, Yoshiki Furukawa, Tokuko Toyota, Shintaro Kinoshita, Yoko Azusawa, Jun Ando, and Miki Ando: Establishment of ganglioside GD2-expressing extranodal NK/T cell lymphoma cell line with scRNA-seq analysis. Experimental Hematology, Nov 2023；S0301-472X(23)01769-1. doi: 10.1016. 59. Chiho Furuya, Hajime Yasuda, Makoto Hiki, Shuichi Shirane, Tomohito Yamana, Ayana Uchimura, Tadaaki Inano, Tomoiku Takaku, Yasuharu Hamano, Miki Ando: Ensitrelvir for treatment of persistent COVID-19 infections in lymphoma patients: a report of two cases. Frontiers in Immunology. Jan 2024 60. Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Midori Ishii, Yoko Azusawa, Yasuharu Hamano, Hidetaka Eguchi, Masami Arai, Jun Ando, Miki Ando: Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia. Heliyon. Jan 2024 61. Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada, Fumiyuki Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa Takahashi, Hiromitsu Nakauchi, Miki Ando: Rejuvenated iPSC-derived GD2-directed CART cells harbor robust cytotoxicity against small cell lung cancer. Cancer Research Communications. Jan 2024 4(3): 723-737 62. Tomonori Ochiai, Hajime Yasuda, Hisaya Akiba, Karin Ashizawa, Erina Hosoya, Jun Ando, Sachiko Miyake, Miki Ando: Ectopic band 3 expression as a cause of mature ovarian teratoma-associated secondary autoimmune hemolytic anemia. International Journal of Laboratory Hematology. Mar 2024 63. Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Ichii M., Okatani T., Omura H., Nakajima K.,Makoto Sasaki, Jun Ando, Tomoiku Takaku, Koike M., Izumiyama K., Hiraga J., Yano T., Usuki K., Ohtsuka E., Yokoyama K., Oyake T., Takahashi N., Nishida T., Nakao T., Fukuda Y., Akasaka T., Mugitani A., Miki Ando, Norio Komatsu: Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology, April 2024 64. Yoshiki Furukawa, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Kota Tachibana, Yoko Azusawa, Takao Kato, Norihide Izumi, Erina Hosoya, Ayana Uchimura, Tadaaki Inano, Shuichi Shirane, Yutaka Tsukune, Tomoiku Takaku, Yasuharu Hamano, Miki Ando: L-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection. British Journal of Haematology, July 2024 65. Naoki Watanabe, Sakiko Harada, Shoko Sato, Yasutaka Fukuda, Yuina Tanaka, Kensuke Yanashima, Eriko Sato, Daisuke Taniguchi, Yuji Tomizawa, Nobutaka Hattori, Miki Ando: Chromosomal abnormalities as a predisposition to secondary neurolymphomatosis in patients with diffuse large B-cell lymphoma: A report of two cases and a literature review. Case Reports in Oncology, Aug 2024 66. Maho Okuda, Marito Araki, Federico De Marchi ,Soji Morishita, Misa Imai, Hanaka Fukada, Miki Ando, Norio Komatsu: Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation. Experimental Hematology, Sep 2024 67. Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Yoko Azusawa, Toru Mitsumori, Eriko Sato, Hina Takano, Yutaka Tsukune, Naoki Watanabe, Tomoiku Takaku, Hajime Yasuda, Yasuharu Hamano, Makoto Sasaki, Shuko Nojiri, Midori Ishii, and Miki Ando: Eleven cases of laryngeal edema after tisagenlecleucel infusion: A 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas. Haematologica, Oct 2024 (IF: 8.2) 68. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Ysutaka Fukuda, Tomonori Ochiai, Shuichi Shirane, Tadaaki Inano, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera. Hematology, Nov 2024 69. Shuichi Shirane, Hajime Yasuda, Ayana Uchimura, Yosuke Mori, Tadaaki Inano, Miyuki Tsutsui, Yasuharu Hamano, Miki Ando: Splenic irradiation preceding allogeneic hematopoietic stem cell transplantation as a possible risk factor of sinusoidal obstruction syndrome: a report of three cases. Case Reports in Oncology, Nov 2024 70. Yoko Edahiro, Shuichi Shirane, Jun Takeda, Hajime Yasuda, Tadaaki Inano, Miyuki Tsutsui, Yasuharu Hamano, Makoto Sasaki, Jun Ando, Atsuo Itakura, Miki Ando, Norio Komatsu: Assessment and management of pregnancy in patients with myeloproliferative neoplasms: Insights from a single-institution study of 29 neonates. International Journal of Hematology, Nov 2024 71. Suzuki Kohjin, Watanabe Naoki, Torii Satoru, Arakawa Satoko, Ochi Kiyosumi, Tsuchiya Shun, Yamada Kazuhiro, Kawamura Yoko, Ota Sadao, Komatsu Norio, Shimizu Shigeomi, Ando Miki, Takaku Tomoiku: BCR::ABL1- induced Mitochondrial Morphological Alterations as a Potential Clinical Biomarker in Chronic Myeloid Leukemia. Cancer Science, Nov 2024

研究テーマ

iPS細胞を用いる若返りT細胞療法

研究業績（論文）

1. Tamayose K, Sugimoto K, Ando M, Oshimi K.
Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts.
Blood 97: 2524, 2001
2. Ando M, Tamayose K, Sugimoto K, Oshimi K.
Secondary myelodysplasticsyndrome after treatment of prostate cancer with oral estramustine.
American Journal of Hematology 67: 274-275, 2001
3. Tamayose K, Sugimoto K, Ando M, Oshimi K.
Mononucleosis syndrome and acute monocytic leukemia.
European Journal of Haematology 68: 236-238, 2002
4. Ando M, Isobe Y, Sasaki M, Sugimoto K, Ando J, Oshimi K.
Diffuse large B-cell lymphoma expressing surface immunoglobulin heavy chain (Ig alpha) and lacking light chains.
Rinsho Ketsueki 46: 492-495, 2005
5. Ando M, Sugimoto K, Kitoh T, Sasaki M, Mukai K, Ando J, Egasira M, Schuster SM, Oshimi K.
Selective apoptosis of natural killer-cell tumours by l-asparaginase.
British Journal of Haematology 130: 860-868, 2005
6. Sasaki M, Sugimoto K, Tamayose K, Ando M, Tanaka Y, Oshimi K.
Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax.
Oncogene 25(26):3621-7, 2006
7. Ando J, Sugimoto K, Tamayose K, Ando M, Kojima Y, Oshimi K.
Cytokine-producing sarcoma mimics eosinophilic leukaemia.
European Journal of Haematology 78: 169-170, 2007
8. Ando J, Sugimoto K, Tamayose K, Sasaki M, Ando M, Oshimi K.
Changes in cell morphology and cytoskeletal organization are induced by human mitotic checkpoint gene, Bub1.
Biochemical Biophysical Research Communication 365: 691-697, 2008
9. Sugimoto K, Sasaki M, Isobe Y, Tsutsui M, Suto H, Ando J, Tamayose K, Ando M, Oshimi K.
Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative
leukemia cell lines through the depletion of Chk1.
Oncogene 27(22):3091-101, 2008
10. Ando J, Sugimoto K, Ando M, Sasaki M, Oshimi K.
CD20-positive extranodal NK-cell lymphoma, nasal-type.
European Journal of Haematology 80: 549-550, 2008
11. Miki Ando, Valentina Hoyos, Shigeki Yagyu, Wade Tao, Carlos A. Ramos, Gianpietro Dotti, Malcolm K. Brenner and Lisa Bouchier-Hayes
Bortezomib sensitizes non small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity
Cancer Gene Therapy 21(11):472-82, 2014
12. Hoyos V, Del Bufalo F, Yagyu S, Ando M, Dotti G, Suzuki M, Bouchier-Hayes L, Alemany R, Brenner MK.
Mesenchymal stromal cells for linked delivery of oncolytic and apoptotic adenoviruses to non-small cell lung cancers
Molecular Therapy 23(9):1497-506, 2015
13. Miki Ando, Toshinobu Nishimura, Satoshi Yamazaki, Tomoyuki Yamaguchi, Ai Kawana-Tachikawa, Tomonari Hayama, Yusuke Nakauchi, Jun Ando, Yasunori Ota, Satoshi Takahashi, Ken Nishimura, Manami Ohtaka, Mahito Nakanishi, John J Miles, Scott R Burrows, Malcolm K Brenner, and Hiromitsu Nakauchi
A Safeguard System for Induced Pluripotent Stem-Cell Derived Rejuvenated T-cell Therapy
Stem Cell Reports 5(4):597-608, 2015
14. Miki Ando and Hiromitsu Nakauchi
“Off-the-shelf” Immunotherapy with iPSC-Derived Rejuvenated Cytotoxic T Lymphocytes
Experimental Hematology 47:2-12, 2017
15. Go Itakura, Soya Kawabata, Miki Ando, Yuichiro Nishiyama, Keiko Sugai, Masahiro Ozaki, Tsuyoshi Iida, Toshiki Ookubo, Kota Kojima, Rei Kashiwagi, Kaori Yasutake, Hiromitsu Nakauchi, Hiroyuki Miyoshi, Narihito Nagoshi, Jun Kohyama, Akio Iwanami, Morio Matsumoto, Masaya Nakamura, and Hideyuki Okano.
Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives
Stem Cell Reports 8(3):673-684, 2017
16. Mana Iizuka-Koga, Hiromitsu Asashima, Miki Ando, Chen-Yi Lai, Shinji Mochizuki, Mahito Nakanishi, Toshinobu Nishimura, Hiroto Tsuboi, Tomoya Hirota, Hiroyuki Takahashi, Isao Matsumoto, Makoto Otsu, Takayuki Sumida
Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome
Stem Cell Reports 8(5):1155-1163, 2017
17. Ando M*, Nakauchi H, Komatsu N.
iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas.
Rinsho Ketsueki 59(7): 932-938, 2018
18. Miki Ando*, Jun Ando, Satoshi Yamazaki, Midori Ishii, Yumi Sakiyama, Sakiko Harada, Tadahiro Honda, Tomoyuki Yamaguchi, Masanori Nojima, Koichi Ohshima, Hiromitsu Nakauchi and Norio Komatsu：Long-term eradication of extranodal NK/T cell lymphoma, nasal type, by iPSC-derived Epstein-Barr virus - specific rejuvenated T cells in vivo.
Haematologica 105(3): 796-807, 2020
19. Jun Ando, Minhtran C. Ngo, Miki Ando, Ann Leen and Cliona M. Rooney: Identification of protective T-cell antigens for smallpox vaccines.
Cytotherapy 22(11): 642-652, 2020
20. Miki Ando*, Jun Ando, Tadahiro Honda, Midori Ishii, Hiromitsu Nakauchi, and Norio Komatsu：iPSC-derived rejuvenated T cell therapy for Extranodal NK/T-cell lymphoma, nasal type.
Juntendo Medical Journal 66(3): 200-205, 2020
21. Tadahiro Honda, Miki Ando*, Jun Ando, Midori Ishii, Yumi Sakiyama, Kazuo Ohara, Tokuko Toyota, Manami Ohtaka, Ayako Masuda, Yasuhisa Terao, Mahito Nakanishi, Hiromitsu Nakauchi*, and Norio Komatsu: Sustainable tumor suppressive effect of iPSC-derived rejuvenated T cells targeting cervical cancers.
Molecular Therapy 28(11): 2394-2405, 2020
22. Jun Ando, Yuji Ueno, Hajime Yasuda, Miki Ando, Yoko Edahiro, Tadahiro Honda, Masashi Takanashi, Daisuke Taniguchi, Nobutaka Hattori, Norio Komatsu: Radiation induced myopathy developing in a Hodgkin lymphoma patient: an autopsy case with systemic muscle sampling.
Case Reports in Oncology 14: 338-342, 2021
23. Tomonori Ochiai, Jun Ando, Sakiko Harada, Makoto Hiki, Miki Ando, Norio Komatsu: Immune thrombocytopenia associated with asymptomatic COVID-19 infection. Rinsho Ketsueki 62(1): 58-60, 2021
24. Yoshiki Furukawa, Jun Ando, Miki Ando*, Shintaro Kinoshita, Yoko Edahiro, Takuya Furuta, Koichi Ohshima, Norio Komatsu: Long-term spontaneous regression of Stage IV diffuse large B-cell lymphoma.
Journal of Clinical and Experimental Hematopathology 61(3): 168-172, 2021
25. Yoshiki Furukawa, Miki Ando*, Yoko Azusawa, Shintaro Kinoshita, Sakiko Harada, Tomonori Ochiai, Tadahiro Honda, Kazuya Sugimoto, Yoko Tabe, Norio Komatsu, Jun Ando: Persistent immune thrombocytopaenic purpura associated with SARS-Cov-2 infection.
eJHaem 2(3): 530-533, 2021
26. Sakiko Harada, Jun Ando, Miki Ando*, Hideaki Nitta, Tadaaki Inano, Yusuke Hirasawa, Yoshiki Furukawa, Shintaro Kinoshita, Koichi Ohshima, Norio Komatsu: High-grade primary central nervous system lymphomatoid granulomatosis: Successfully rituximab monotherapy
Internal Medicine 60(23): 3795-3799, 2021
27. Takeshi Mori, Hiroshi Abe, Mitutaka Yoshida, Yutaka Tsukune, Yuriko Yahata, Tomoiku Takaku, Jun Ando, Miki Ando, Shinichi Torii, and Makoto Sasaki: Immunohistochemical detection of aflatoxin in lesions of aflatoxin-producing Aspergillus flavus infection. Medical Mycology Journal 62(3): 47-52, 2021
28. Shintaro Kinoshita, Jun Ando, Miki Ando*, Norio Komatsu: Primary lymphoma of the pericardium.
Internal Medicine 60(24): 4005-4006, 2021
29. Sakiko Harada, Jun Ando, Miki Ando*, Yoko Azusawa, Tomonori Ochiai, Yoshinori Hashimoto, Yusuke Hirasawa, Norio Komatsu: Sarcoma-like appearance but pathologic Hodgkin lymphoma.
International Journal of Hematology 114:1-2, 2021
30. Kazuo Ohara, Shintaro Kinoshita, Jun Ando, Yoko Azusawa, Midori Ishii, Sakiko Harada, Yoichiro Mitsuishi, Tetsuhiko Asao, Ken Tajima, Taketsugu Yamamoto, Fumiyuki Takahashi, Norio Komatsu, Kazuhisa Takahashi, Miki Ando*: SCLC-J1, a novel small cell lung cancer cell line.
Biochemistry and Biophysics Reports 27: 101089, 2021
31. Midori Ishii, Jun Ando, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Yoshiki Furukawa, Yoshiyuki Suehara, Mahito Nakanishi, Kazutaka Nakashima, Koichi Ohshima, Hiromitsu Nakauchi, Miki Ando*: iPSC-derived neoantigen-specific cytotoxic T lymphocyte therapy for Ewing sarcoma
Cancer Immunology Research 9(10): 1175-1186, 2021
32. Shintaro Kinoshita, Miki Ando*, Jun Ando, Midori Ishii, Yoshiki Furukawa, Osamu Tomita, Shuichi Shirane, Yoshihito Kishita, Yukiko Yatsuka, Hidetaka Eguchi, Yasushi Okazaki, and Norio Komatsu: Trigenic ADH5 / ALDH2 / ADGRV1 mutations in myelodysplasia with Usher syndrome.
Heliyon, 7(8), e07804, 2021
33. Sakiko Harada, Miki Ando*, Jun Ando, Midori Ishii, Tomoyuki Yamaguchi, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Yozo Nakazawa, Hiromitsu Nakauchi*, and Norio Komatsu: Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomas.
Molecular Therapy 30 (2): 534-549, 2022
34. Yoshiki Furukawa, Yasuharu Hamano, Shuichi Shirane, Shintaro Kinoshita, Yoko Azusawa, Jun Ando, Hiromitsu Nakauchi and Miki Ando: Advances in allogeneic cancer cell therapy and future perspectives on “off-the-shelf” T cell therapy using iPSC technology and gene editing.
Cells 11: 269, 2022
35. Naoki Watanabe, Tomoiku Takaku, Yutaka Tsukune, Hajime Yasuda, Tomonori Ochiai, Kohei Yamada, Hiroki Nakazawa, Saori Hotta, Takayasu Nishimaki, Haruhi Takagi, Kazuhisa Takahashi, Norio Komatsu, Miki Ando: Bosutinib-induced lung injury: A report of two cases and literature review.
International Journal of Hematology 115(6): 902-905, 2022.
36. Ayana Uchimura, Hajime Yasuda, Jun Ando, Yasunori Ota, Makoto Sasaki, Tomoiku Takaku, Yutaka Tsukune, Miyuki Tsutsui, Yoko Edahiro, Naoki Watanabe, Tomonori Ochiai, Norio Komatsu, Miki Ando: Hodgkin lymphoma on hemodialysis successfully treated with extended courses of brentuximab vedotin.
Case Reports in Oncology 15(1): 263-266, 2022
37. Hajime Yasuda, Taku Hatano, Tadahiro Honda, Miyuki Tsutsui, Nobutaka Hattori, Miki Ando, Norio Komatsu: Vitamin B6 deficiency anemia attributed to levodopa/carbidopa intestinal gel therapy for Parkinson’s disease: a diagnostic pitfall for myelodysplastic syndrome with ring sideroblasts.
Internal Medicine, March 2022
38. Hajime Yasuda, Yoshiki Furukawa, Kenya Nishioka, Makoto Sasaki, Yutaka Tsukune, Shuichi Shirane, Nobutaka Hattori, Miki Ando, Norio Komatsu: Vitamin B6 deficiency as a cause of polyneuropathy in POEMS syndrome: rapid recovery with supplementation in two cases.
Hematology (Taylor & Francis), March 2022
39. Hajime Yasuda, Jun Ando, Sayako Yoshida, Yasunori Ota, Norio Komatsu, Miki Ando: Diffuse large B-cell lymphoma with adrenal involvement presenting as other iatrogenic immunodeficiency-associated lymphoproliferative disorders: sustained remission with methotrexate termination alone in two cases.
Internal Medicine, May 2022
40. Federico De Marchi, Maho Okuda, Soji Morishita, Misa Imai, Terumi Baba, Mei Horino, Yosuke Mori, Chiho Furuya, Satoko Ogata, Yinjie Yang, Jun Ando, Miki Ando, Marito Araki, Norio Komatsu: Clinical and biological relevance of CREB3L1 in Philadelphia 1 chromosome-negative myeloproliferative neoplasms.
Leukemia Research, May 2022
41. Yosuke Mori, Marito Araki, Soji Morishita, Misa Imai, Yoko Edahiro, Masafumi Ito, Tomonori Ochiai, Shuichi Shirane, Yoshinori Hashimoto, Hajime Yasuda, Jun Ando, Miki Ando, Norio Komatsu: Clinical features of acquired erythrocytosis: low level of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients.
Cancer Medicine, June 2022
42. Hajime Yasuda, Norio Komatsu, Jun Ando, Miki Ando: Hodgkin lymphoma on hemodialysis: a review of treatment and recommendations. Clinical Lymphoma, Myeloma and Leukemia, July 2022
43. Naoki Watanabe, Tomoiku Takaku, Isao Fujioka, Shun Tsuchiya, Miki Ando: Bosutinib-induced late-onset severe liver injury preceded by eosinophilia. Annals of Hematology, Aug 2022
44. Hajime Yasuda, Yasunobu Hoshino, Jun Ando, Mayu Miyachi, Monami Osawa, Nobutaka Hattori, Miki Ando: Vitamin B6 deficiency polyneuropathy and dermatitis. The American Journal of Medicine, Sep 2022
45. Hajime Yasuda, Yuji Tomizawa, Sakiko Harada, Makoto Sasaki, Norio Komatsu, Jun Ando, Nobutaka Hattori, Miki Ando: Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib. Heliyon, Oct 2022
46. Soji Morishita, Yoshinori Hashimoto, Chiho Furuya, Yoko Edahiro, Tomonori Ochiai, Shuichi Shirane, Tadaaki Inano, Hajime Yasuda, Miki Ando, Marito Araki, Norio Komatsu: Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia. European Journal of Haematology, Oct 2022
47. Chang Liu, Misa Imai, Yoko Edahiro, Shuichi Mano, Hiraku Takei, Mai Nudejima, Akira Kurose, Soji Morishita, Miki Ando, Satoshi Tsuneda, Marito Araki, Norio Komatsu: Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms. Experimental Hematology, Nov 2022
48. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia. Journal of Thrombosis and Thrombolysis, Dec 2022
49.　Koji Tsuchiya, Yoko Edahiro, Tomoiku Takaku, Jun Ando, Miki Ando, Takashi Miida, Kinya Uchihashi, Yoko Tabe: Examinations of bone marrow aspirate using the automated hematology analyzer Sysmex XN-3000. International Journal of Laboratory Hematology, Feb 2023
50. Shun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, Miki Ando. Management and risk factors of pleural effusion in Japanese chronic myeloid leukemia patients treated with first-line dasatinib in real-world clinical practice. Internal Medicine, Feb 2023
51. Yoko Edahiro , Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, Motoaki Shiratsuchi, Kei Nakajima, Eiichi Ohtsuka, Hiroaki Tanaka, Eri Kawata, Mika Nakamae, Yasunori Ueda, Yasuo Aota, Yasumasa Sugita, Shin Ohara, Satoshi Yamasaki, Kohsuke Asagoe, Shuro Yoshida, Jun Yamanouchi, Sayaka Suzuki, Toshinori Kondo, Yuji Kanisawa, Kohtaro Toyama, Hiromi Omura, Daisuke Mizuchi, Sumio Sakamaki, Miki Ando, Norio Komatsu: Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosisk. International Journal of Hematology, Mar 2023
52. Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi and Kazuya Shimoda: Nationwide Prospective Survey of Secondary Myelofibrosis in Japan: Superiority of DIPSS-plus to MYSEC-PM as a Survival Risk Model. Blood Cancer Journal, Jun 2023；13(1): 110. doi: 10.1038/s41408-023-00869-9.
53. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano,　Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology, Jun 2023
54. Hajime Yasuda, Hikari Taka, Naoko Kaga, Tomonori Ochiai, Tomohito Yamana, Miura Yoshiki, Midori Ishii, Makoto Sasaki, Jun Ando, Miki Ando: Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma. Cancer Chemotherapy and Pharmacology, Sep 2023
55. Chiho Furuya, Soji Morishita, Yoshinori Hashimoto, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients. British Journal of Haematology, Oct 2023
56. Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi, and Kazuya Shimoda: Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Annals of Hematology, Nov 2023
57. Yoshiki Furukawa*, Midori Ishii*, Jun Ando, Kazuya Ikeda, Kyomi J. Igarashi, Shintaro Kinoshita, Yoko Azusawa, Tokuko Toyota, Tadahiro Honda, Mahito Nakanishi, Koichi Ohshima, Ayako Masuda, Emiko Yoshida, Mari Kitade, Matthew Porteus, Yasuhisa Terao, Hiromitsu Nakauchi, and Miki Ando: iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer. Cell Reports Medicine, Nov 2023; 4(12): 101327. doi: 10.1016.
*co-first author
58. Shoko Sato, Midori Ishii, Kota Tachibana, Yoshiki Furukawa, Tokuko Toyota, Shintaro Kinoshita, Yoko Azusawa, Jun Ando, and Miki Ando: Establishment of ganglioside GD2-expressing extranodal NK/T cell lymphoma cell line with scRNA-seq analysis. Experimental Hematology, Nov 2023；S0301-472X(23)01769-1. doi: 10.1016.
59. Chiho Furuya, Hajime Yasuda, Makoto Hiki, Shuichi Shirane, Tomohito Yamana, Ayana Uchimura, Tadaaki Inano, Tomoiku Takaku, Yasuharu Hamano, Miki Ando: Ensitrelvir for treatment of persistent COVID-19 infections in lymphoma patients: a report of two cases. Frontiers in Immunology. Jan 2024
60. Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Midori Ishii, Yoko Azusawa, Yasuharu Hamano, Hidetaka Eguchi, Masami Arai, Jun Ando, Miki Ando: Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia. Heliyon. Jan 2024
61. Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada, Fumiyuki Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa Takahashi, Hiromitsu Nakauchi*, Miki Ando*: Rejuvenated iPSC-derived GD2-directed CART cells harbor robust cytotoxicity against small cell lung cancer. Cancer Research Communications. Jan 2024 4(3): 723-737
62. Tomonori Ochiai, Hajime Yasuda, Hisaya Akiba, Karin Ashizawa, Erina Hosoya, Jun Ando, Sachiko Miyake, Miki Ando: Ectopic band 3 expression as a cause of mature ovarian teratoma-associated secondary autoimmune hemolytic anemia. International Journal of Laboratory Hematology. Mar 2024
63. Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Ichii M., Okatani T., Omura H., Nakajima K.,Makoto Sasaki, Jun Ando, Tomoiku Takaku, Koike M., Izumiyama K., Hiraga J., Yano T., Usuki K., Ohtsuka E., Yokoyama K., Oyake T., Takahashi N., Nishida T., Nakao T., Fukuda Y., Akasaka T., Mugitani A., Miki Ando, Norio Komatsu: Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology, April 2024
64. Yoshiki Furukawa, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Kota Tachibana, Yoko Azusawa, Takao Kato, Norihide Izumi, Erina Hosoya, Ayana Uchimura, Tadaaki Inano, Shuichi Shirane, Yutaka Tsukune, Tomoiku Takaku, Yasuharu Hamano, Miki Ando: L-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection. British Journal of Haematology, July 2024
65. Naoki Watanabe, Sakiko Harada, Shoko Sato, Yasutaka Fukuda, Yuina Tanaka, Kensuke Yanashima, Eriko Sato, Daisuke Taniguchi, Yuji Tomizawa, Nobutaka Hattori, Miki Ando: Chromosomal abnormalities as a predisposition to secondary neurolymphomatosis in patients with diffuse large B-cell lymphoma: A report of two cases and a literature review. Case Reports in Oncology, Aug 2024
66. Maho Okuda, Marito Araki, Federico De Marchi ,Soji Morishita, Misa Imai, Hanaka Fukada, Miki Ando, Norio Komatsu: Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation. Experimental Hematology, Sep 2024
67. Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Yoko Azusawa, Toru Mitsumori, Eriko Sato, Hina Takano, Yutaka Tsukune, Naoki Watanabe, Tomoiku Takaku, Hajime Yasuda, Yasuharu Hamano, Makoto Sasaki, Shuko Nojiri, Midori Ishii, and Miki Ando: Eleven cases of laryngeal edema after tisagenlecleucel infusion: A 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas. Haematologica, Oct 2024 (IF: 8.2)
68. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Ysutaka Fukuda, Tomonori Ochiai, Shuichi Shirane, Tadaaki Inano, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu: A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera. Hematology, Nov 2024
69. Shuichi Shirane, Hajime Yasuda, Ayana Uchimura, Yosuke Mori, Tadaaki Inano, Miyuki Tsutsui, Yasuharu Hamano, Miki Ando: Splenic irradiation preceding allogeneic hematopoietic stem cell transplantation as a possible risk factor of sinusoidal obstruction syndrome: a report of three cases. Case Reports in Oncology, Nov 2024
70. Yoko Edahiro, Shuichi Shirane, Jun Takeda, Hajime Yasuda, Tadaaki Inano, Miyuki Tsutsui, Yasuharu Hamano, Makoto Sasaki, Jun Ando, Atsuo Itakura, Miki Ando, Norio Komatsu: Assessment and management of pregnancy in patients with myeloproliferative neoplasms: Insights from a single-institution study of 29 neonates. International Journal of Hematology, Nov 2024
71. Suzuki Kohjin, Watanabe Naoki, Torii Satoru, Arakawa Satoko, Ochi Kiyosumi, Tsuchiya Shun, Yamada Kazuhiro, Kawamura Yoko, Ota Sadao, Komatsu Norio, Shimizu Shigeomi, Ando Miki, Takaku Tomoiku: BCR::ABL1- induced Mitochondrial Morphological Alterations as a Potential Clinical Biomarker in Chronic Myeloid Leukemia. Cancer Science, Nov 2024

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

安藤 美樹（アンドウ ミキ）

安藤美樹（アンドウミキ）